New addiction society guidance on medetomidine’s brutal withdrawal
It wasn’t until autumn, when patients started coming in with excruciating withdrawal symptoms, that doctors knew something had dangerously shifted.
Key points
- It raised some red flags, but amid a constantly changing drug supply, not many.
- None of the patients died, and most went home from the hospital the same day.
Clinicians first noticed medetomidine in the Philadelphia drug supply during the spring of 2024.
There was a cluster of overdoses one weekend, leaving patients more sedated and with lower heart rates than normal after receiving the reversal medication naloxone.
How this summary was made: extractive summary — built from the sources' own reporting. It is drawn only from the reporting of the sources listed below — read the originals for full detail. How we summarize →
Advertisement
Every article behind this summary — 1 article from 1 outlet
Get stories like this in your inbox.
Subscribe — it's freeOne free email at 6am — your topics, deduplicated, five minutes. No account, no paywall.